新型冠状病毒（SARS-CoV-2）与α-1抗胰蛋白酶缺乏症有关吗？ - Suppr

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?

作者信息

Rodríguez-García Carlota, Rodríguez-Ruiz Emilio, Ruano-Raviña Alberto, Cruz Raquel, Piñeiro-Lamas María, Casal Ana, Lapunzina Pablo, Carracedo Ángel, Valdés Luis

机构信息

Pulmonology Department, Clinical University Hospital of Santiago, Santiago de Compostela, Spain.

Clinical University Hospital of Santiago, Santiago de Compostela, Spain.

出版信息

J Thorac Dis. 2023 Feb 28;15(2):711-717. doi: 10.21037/jtd-22-1062. Epub 2023 Jan 29.

DOI:10.21037/jtd-22-1062

PMID:36910046

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9992632/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff8f/9992632/b03be64b05a9/jtd-15-02-711-f1.jpg

相似文献

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?新型冠状病毒（SARS-CoV-2）与α-1抗胰蛋白酶缺乏症有关吗？

J Thorac Dis. 2023 Feb 28;15(2):711-717. doi: 10.21037/jtd-22-1062. Epub 2023 Jan 29.

Correlation of alpha-1 antitrypsin levels and exosome associated neutrophil elastase endothelial injury in subjects with SARS-CoV2 infection.在 SARS-CoV2 感染患者中，α-1 抗胰蛋白酶水平与外泌体相关的中性粒细胞弹性蛋白酶内皮损伤的相关性。

PLoS One. 2022 Sep 9;17(9):e0274427. doi: 10.1371/journal.pone.0274427. eCollection 2022.

SARS-CoV-2 infection in alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中的 SARS-CoV-2 感染。

Respir Med. 2021 Aug;184:106466. doi: 10.1016/j.rmed.2021.106466. Epub 2021 May 13.

A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.静脉注射血浆纯化的α-1 抗胰蛋白酶治疗 SARS-CoV-2 诱导的急性呼吸窘迫综合征的随机、双盲、安慰剂对照、初步临床试验：一项随机对照试验研究方案的结构化总结。

Trials. 2021 Apr 19;22(1):288. doi: 10.1186/s13063-021-05254-0.

Lower serum alpha 1 antitrypsin levels in patients with severe COVID-19 compared with patients hospitalized due to non-COVID-19 pneumonia.与因非 COVID-19 肺炎住院的患者相比，重症 COVID-19 患者的血清 alpha 1 抗胰蛋白酶水平较低。

Infect Dis (Lond). 2022 Dec;54(12):846-851. doi: 10.1080/23744235.2022.2111464. Epub 2022 Aug 17.

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.抗胰蛋白酶缺乏症患者的 Alpha 1 抗胰蛋白酶治疗：来自注册研究的观点和 COVID-19 大流行期间自我管理的实际考虑。

Int J Chron Obstruct Pulmon Dis. 2021 Nov 1;16:2983-2996. doi: 10.2147/COPD.S325211. eCollection 2021.

Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate.新冠病毒宿主基因组学：有证据表明，α1 抗胰蛋白酶缺乏症可能是导致更高死亡率的一个潜在危险因素。

Med Hypotheses. 2021 Feb;147:110485. doi: 10.1016/j.mehy.2021.110485. Epub 2021 Jan 9.

Alpha-1 Antitrypsin Deficiency: Home Therapy.α-1抗胰蛋白酶缺乏症：家庭治疗

Front Pharmacol. 2021 Apr 15;12:575402. doi: 10.3389/fphar.2021.575402. eCollection 2021.

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale.严重的α1-抗胰蛋白酶缺乏症患者的 COVID-19 感染：寻找发病机制。

Respir Med. 2021 Jul;183:106440. doi: 10.1016/j.rmed.2021.106440. Epub 2021 Apr 30.

Assessment of Patient Perspectives and Barriers to Self-Infusion of Augmentation Therapy for Alpha-1 Antitrypsin Deficiency During the COVID-19 Pandemic.COVID-19大流行期间α-1抗胰蛋白酶缺乏症增强治疗患者自我输注的观点及障碍评估

Pulm Ther. 2022 Mar;8(1):95-103. doi: 10.1007/s41030-022-00182-z. Epub 2022 Jan 24.

引用本文的文献

Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia.新冠病毒肺炎患者的α-1抗胰蛋白酶：马来西亚的一项双中心筛查研究

Ann Saudi Med. 2025 Jul-Aug;45(4):225-234. doi: 10.5144/0256-4947.2025.225. Epub 2025 Aug 7.

Hospital Admission Trends in Alpha-1-Antitrypsin Deficiency: A Sex-Based Analysis from the Spanish National Discharge Database, 2016-2022.α-1抗胰蛋白酶缺乏症的医院入院趋势：基于性别的分析，来自西班牙国家出院数据库，2016 - 2022年

J Clin Med. 2024 Oct 31;13(21):6564. doi: 10.3390/jcm13216564.

Proteomics Clustering Research of ITRAQ Markers in Plasma of AIDS Patients with Different Chinese Medicine Syndromes.艾滋病不同中医证型患者血浆中ITRAQ标记物的蛋白质组学聚类研究

Iran J Public Health. 2024 Feb;53(2):376-386. doi: 10.18502/ijph.v53i2.14922.

A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning.通过血浆抗体微阵列和机器学习确定的危重症新冠患者的蛋白质组学特征减少

Clin Proteomics. 2024 May 17;21(1):33. doi: 10.1186/s12014-024-09488-3.

Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation.中性粒细胞蛋白酶通过降解刺突蛋白和抑制病毒介导的炎症反应对 SARS-CoV-2 具有保护作用。

JCI Insight. 2024 Apr 8;9(7):e174133. doi: 10.1172/jci.insight.174133.

本文引用的文献

Novel genes and sex differences in COVID-19 severity.新型冠状病毒病严重程度的相关基因及性别差异。

Hum Mol Genet. 2022 Nov 10;31(22):3789-3806. doi: 10.1093/hmg/ddac132.

A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19.一项关于静脉注射α-1抗胰蛋白酶治疗新型冠状病毒肺炎继发急性呼吸窘迫综合征的随机、双盲、安慰剂对照试验。

Med. 2022 Apr 8;3(4):233-248.e6. doi: 10.1016/j.medj.2022.03.001. Epub 2022 Mar 11.

Mapping the human genetic architecture of COVID-19.绘制人类 COVID-19 遗传结构图谱。

Nature. 2021 Dec;600(7889):472-477. doi: 10.1038/s41586-021-03767-x. Epub 2021 Jul 8.

SARS-CoV-2 infection in alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中的 SARS-CoV-2 感染。

Respir Med. 2021 Aug;184:106466. doi: 10.1016/j.rmed.2021.106466. Epub 2021 May 13.

Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.α1抗胰蛋白酶是严重急性呼吸综合征冠状病毒2引发蛋白酶TMPRSS2的一种抑制剂。

Pathog Immun. 2021 Apr 26;6(1):55-74. doi: 10.20411/pai.v6i1.408. eCollection 2021.

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale.严重的α1-抗胰蛋白酶缺乏症患者的 COVID-19 感染：寻找发病机制。

Respir Med. 2021 Jul;183:106440. doi: 10.1016/j.rmed.2021.106440. Epub 2021 Apr 30.

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort.α-1抗胰蛋白酶缺乏症的严重程度与新型冠状病毒肺炎的风险：一项葡萄牙队列研究。

Respir Med. 2021 May;181:106387. doi: 10.1016/j.rmed.2021.106387. Epub 2021 Apr 2.

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.α-1 抗胰蛋白酶抑制 TMPRSS2 蛋白酶活性和 SARS-CoV-2 感染。

Nat Commun. 2021 Mar 19;12(1):1726. doi: 10.1038/s41467-021-21972-0.

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.α1抗胰蛋白酶缺乏症与新型冠状病毒肺炎风险：紧急行动呼吁

Lancet Respir Med. 2021 Apr;9(4):337-339. doi: 10.1016/S2213-2600(21)00018-7. Epub 2021 Jan 21.

Med Hypotheses. 2021 Feb;147:110485. doi: 10.1016/j.mehy.2021.110485. Epub 2021 Jan 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献